HealthQuad has announced the final close of its second fund, HealthQuad Fund-II, with a total subscription of $162 million, more than 2.2X greater than its target size at launch.
MSD, the global biopharmaceutical company, led commitments from global financial investors, strategic institutions in pharma and healthcare, development financial institutions (DFI), funds of funds, and large European conglomerates.
HealthQuad Fund-II is investing in 10-15 young private companies across high-growth segments of the healthcare sector in India, aiming to generate value as well as achieve deep social impact.